Adverse event following immunization surveillance systems for pregnant women and their infants: A systematic review

Pharmacoepidemiology and Drug Safety

Volumn 24, Issue 4, 2015, Pages 361-367

  Cassidy, Christine ^a   Macdonald, Noni E ^b,c   Steenbeek, Audrey ^a,c   Top, Karina A ^b,c  

^a DALHOUSIE UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c IWK HEALTH CENTRE   (Canada)

Author keywords

Active surveillance; Adverse event following immunization; Passive surveillance; Pharmacoepidemiology; Pregnancy; Vaccination

Indexed keywords

CHICKENPOX VACCINE; SMALLPOX VACCINE; VACCINE; WART VIRUS VACCINE;

ACTIVE IMMUNIZATION; ADVERSE OUTCOME; ARTICLE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; FEMALE; HUMAN; IMMUNIZATION; INFANT; OUTCOME ASSESSMENT; PASSIVE IMMUNIZATION; PREGNANCY; PREGNANCY OUTCOME; PREGNANT WOMAN; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; PROGENY; SIDE EFFECT; SYSTEMATIC REVIEW; ADVERSE EFFECTS; HEALTH SURVEY; MEDLINE; STATISTICS AND NUMERICAL DATA;

ADVERSE DRUG REACTION REPORTING SYSTEMS; FEMALE; HUMANS; IMMUNIZATION; INFANT; POPULATION SURVEILLANCE; PREGNANCY; PUBMED;

EID: 84925940223     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3754     Document Type: Article

References (38)

1. Ten great public health achievements-United States, 1900-1999. Morb Mortal Wkly Rep 1999; 48: 241-243.
2. Rasmussen SA, Watson AK, Kennedy ED, Broder KR, Jamieson DJ. Vaccines and pregnancy: past, present, and future. Semin Fetal Neonatal Med 2014; 19(3): 161-169. doi:10.1016/j.siny.2013.11.014.
3. World Health Organization. Background paper on influenza vaccines and immunization: SAGE working group, 2012. Available at: http://www.who.int/immunization/sage/meetings/2012/april/1_Background_Paper_Mar26_v13_cleaned.pdf?ua=1 [3 July 2014].
4. World Health Organization. Maternal immunization against tetanus: integrated management of pregnancy and childbirth, 2006. Available at: http://www.who.int/reproductivehealth/publications/maternal_perinatal_health/immunization_tetanus.pdf [3 July 2014].
5. Centers for Disease Control and Prevention. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women-Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb Mortal Wkly Rep 2013; 62(7): 131-135.
6. Munoz FM, Englund JA. Vaccines in pregnancy. Infect Dis Clin North Am 2001; 15(1): 253-271.
7. Gruber MF. Maternal immunization US FDA regulatory considerations. Vaccine 2003; 21(24): 3487-3491.
8. Baggs J, Gee J, Lewis E, et al. The vaccine safety datalink: a model for monitoring immunization safety. Pediatrics 2011; 127: S45-S53. doi:10.1542/peds.2010-1722H.
9. Singleton JA, Lloyd JC, Mootrey GT, Salive ME, Chen RT. An overview of the vaccine adverse event reporting system (VAERS) as a surveillance system. VAERS Working Group. Vaccine 1999; 17(22): 2908-2917.
10. Glasziou P, Del Mar C. Evidence-based Medicine Workbook. BMJ, Canada: Canberra, Australia, 2003, 132 p.
11. Golder S, Loke YK. The performance of adverse effects search filters in MEDLINE and EMBASE. Health Info Libr J 2012; 29(2): 141-151. doi:10.1111/j.1471-1842.2012.00980.x.
12. Angelo MG, Zima J, Tavares Da Silva F, Baril L, Arellano F. Post-licensure safety surveillance for human papillomavirus-16/18-AS04-adjuvanted vaccine: more than 4years of experience. Pharmacoepidemiol Drug Saf 2014; 23(5): 456-465. doi:10.1002/pds.3593.
13. Kallen B, Olausson PO. Vaccination against H1N1 influenza with pandemrix((R)) during pregnancy and delivery outcome: a Swedish register study. BJOG 2012; 119(13): 1583-1590. doi:10.1111/j.1471-0528.2012.03470.x.
14. Shields KE, Galil K, Seward J, Sharrar RG, Cordero JF, Slater E. Varicella vaccine exposure during pregnancy: data from the first 5years of the pregnancy registry. Obstet Gynecol 2001; 98(1): 14-19.
15. Ryan MA, Seward JF, Smallpox Vaccine in Pregnancy Registry Team. Pregnancy, birth, and infant health outcomes from the national smallpox vaccine in pregnancy registry, 2003-2006. Clin Infect Dis 2008; 46(Suppl 3): S221-S226. doi:10.1086/524744.
16. Wilson E, Goss MA, Marin M, et al. Varicella vaccine exposure during pregnancy: data from 10years of the pregnancy registry. J Infect Dis 2008; 197(Suppl 2): S178-S184. doi:10.1086/522136.
17. Chambers CD, Johnson D, Xu R, et al. Risks and safety of pandemic H1N1 influenza vaccine in pregnancy: birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants. Vaccine 2013; 31(44): 5026-5032. doi:10.1016/j.vaccine.2013.08.097.
18. Schatz M, Chambers CD, Jones KL, Louik C, Mitchell AA. Safety of influenza immunizations and treatment during pregnancy: the vaccines and medications in pregnancy surveillance system. Am J Obstet Gynecol 2011; 204(6 Suppl 1): S64-S68. doi:10.1016/j.ajog.2011.01.04.
19. Kharbanda EO, Vazquez-Benitez G, Shi WX, et al. Assessing the safety of influenza immunization during pregnancy: the vaccine safety datalink. Am J Obstet Gynecol 2012; 207(3 Suppl): S47-S51. doi:10.1016/j.ajog.2012.06.073.
20. Moro PL, Broder K, Zheteyeva Y, et al. Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the vaccine adverse event reporting system. Am J Obstet Gynecol 2011; 205(5): 473.e1-473.e9.
21. Moro PL, Museru OI, Niu M, Lewis P, Broder K. Reports to the vaccine adverse event reporting system after hepatitis A and hepatitis AB vaccines in pregnant women. Am J Obstet Gynecol 2014; 210(6): 561.e1-561.e6. doi:10.1016/j.ajog.2013.12.036.
22. Zheteyeva YA, Moro PL, Tepper NK, et al. Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women. Am J Obstet Gynecol 2012; 207(1): 59.e1-59.e7.
23. Zheteyeva Y, Moro PL, Yue X, Broder K. Safety of meningococcal polysaccharide-protein conjugate vaccine in pregnancy: a review of the vaccine adverse event reporting system. Am J Obstet Gynecol 2013; 208(6): 478.e1-478.e6.
24. Khromava A, Cohen CJ, Mazur M, Kanesa-thasan N, Crucitti A, Seifert H. Manufacturers' postmarketing safety surveillance of influenza vaccine exposure in pregnancy. Am J Obstet Gynecol 2012; 207(3 Suppl): S52-S56. doi:10.1016/j.ajog.2012.06.074.
25. Auffret M, Bene J, Gautier S, Moreau-Crepeaux S, Caron J. Pharmacovigilance monitoring of a cohort of pregnant women vaccinated against influenza A(H1N1) variant virus in the Nord-Pas de Calais region of northern France. Eur J Obstet Gynecol Reprod Biol 2013; 170(1): 114-118. doi:10.1016/j.ejogrb.2013.05.025.
26. Carcione D, Blyth CC, Richmond PC, Mak DB, Effler PV. Safety surveillance of influenza vaccine in pregnant women. Aust N Z J Obstet Gynaecol 2013; 53(1): 98-99. doi:10.1111/ajo.12034.
27. Huang WT, Chen WC, Teng HJ, et al. Adverse events following pandemic A (H1N1) 2009 monovalent vaccines in pregnant women-Taiwan, November 2009-August 2010. PLoS One 2011; 6(8): e23049.
28. American Academy of Allergy Asthma and Immunology. Vaccines and medication in pregnancy surveillance system, 2014. Available at: http://www.aaaai.org/about-the-aaaai/strategic-relationships/vampss/vampss-consumer.aspx [3 July 2014].
29. Centres of Disease Control and Prevention, Food and Drug Administration. Vaccine adverse event reporting system. Available at: https://vaers.hhs.gov/index [3 July 2014].
30. World Health Organization. The importance of pharmacovigilance-safety monitoring of medicinal products. Chapter 4. Pharmacovigilance in Drug Regulation. Available at: http://apps.who.int/medicinedocs/en/d/Js4893e/5.html [3 July 2014].
31. Public Health Agency of Canada. Report of adverse events following immunization (AEFI). Available at: http://www.phac-aspc.gc.ca/im/vs-sv/index-eng.php [9 July 2014].
32. Australian Government Department of Health. Adverse events following immunisation (AEFI). Available at: http://www.immunise.health.gov.au/internet/immunise/publishing.nsf/Content/aefi.htm#database [9 July 2014].
33. Australian Government Department of Health. National adverse events following immunisation (AEFI) reporting form. Available at: http://www.tga.gov.au/pdf/forms/problem-medicine-aefi-vaccine-form-140312.pdf [14 July 2014].
34. Sato HK, Sanajotta AT, Moraes JC, et al. Rubella vaccination of unknowingly pregnant women: the São Paulo experience, 2001. J Infect Dis 2011; 204(Suppl 2): S737-S744. doi:10.1093/infdis/jir419.
35. Castillo-Solórzano C, Reef SE, Morice A, et al. Rubella vaccination of unknowingly pregnant women during mass campaigns for rubella and congenital rubella syndrome elimination, the Americas 2001-2008. J Infect Dis 2011; 204(Suppl 2): S713-S717. doi:10.1093/infdis/jir489.
36. Soares RC, Siqueira MM, Toscano CM, et al. Follow-up study of unknowingly pregnant women vaccinated against rubella in Brazil, 2001-2002. J Infect Dis 2011; 204(Suppl 2): S729-S736. doi:10.1093/infdis/jir429.
37. Kharbanda EO, Vazquez-Benitez G, Lipkind HS, et al. Evaluation of the association of maternal pertussis vaccination with obstetric events and birth outcome. JAMA 2014; 312(18): 1897-1904. doi:10.1001/jama.2014.14825.
38. Nordin JD, Kharbanda EO, Vazquez Benitez G, Lipkind H, Vellozzi C, DeStefano D. Maternal influenza vaccine and risk for preterm or small for gestational age birth. J Pediatr 2014; 154(5): 1051.e2-1057.e2. doi:10.1016/j.jpeds.2014.01.037.